Biopharmaceutical characterisation of herbal medicinal products

Pharmazeutische Industrie

Volumn 63, Issue 10, 2001, Pages 1005-1010

  Lang, F ^a   Arzneimittel, W S ^a  

^a DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; BELLADONNA ALKALOID; BUCKTHORN EXTRACT; EMODIN; EXCIPIENT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERFORIN; HYPERICIN; IPECAC; SENNA EXTRACT; SILIBININ; UNCLASSIFIED DRUG; VALERIAN;

BIOEQUIVALENCE; CHEMICAL COMPOSITION; DRUG BIOAVAILABILITY; DRUG CLASSIFICATION; DRUG FORMULATION; DRUG QUALITY; DRUG SOLUBILITY; EUROPE; HERBAL MEDICINE; HYPERICUM PERFORATUM; PRACTICE GUIDELINE; REVIEW; RHUBARB; SILYBUM MARIANUM; UNITED STATES;

EID: 0035169508     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. FIP-Guidelines for dissolution testing of solid oral products
2. Considerations on future pharmacopoeial monographs for plant extracts
3. Biopharmaceutical characterisation of herbal medicinal products: Are in vivo studies necessary?
4. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
5. The biopharmaceutical classification system (BCS): Class III drugs - Better candidates for BA/BE waiver?
6. Untersuchungen zum freisetzungsverhalten und zur bioäqulvalenz von silymarin-präparaten
7. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin
8. Oral bioavailability of hyperforin from Hypericum extracts in rats and human volunteers
9. Empfehlung einer einheitlichen spezifikation für silymarin-fertigarzneimittel